Collegium Pharmaceutical, Inc. (COLL) Revenue Growth
Collegium Pharmaceutical, Inc. (COLL) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 1564.29% |
| 2018-12-31 | 884.73% |
| 2019-12-31 | 5.81% |
| 2020-12-31 | 4.49% |
| 2021-12-31 | -10.69% |
| 2022-12-31 | 67.56% |
| 2023-12-31 | 22.17% |
| 2024-12-31 | 11.41% |
| 2025-12-31 | 23.62% |
How COLL compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| PAHC | Phibro Animal Health Corporation | 27.37% |
| BSX | Boston Scientific Corporation | 19.87% |
| CERS | Cerus Corporation | 16.13% |
| MCK | McKesson Corporation | 12.36% |
| CI | The Cigna Group | 11.24% |
These are five companies in the same sector as COLL with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Collegium Pharmaceutical, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("COLL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | COLL | $24.30 | +1.25% | 0.84M |
| 3 | ||||
| 4 | ||||
| 5 |